Dark Forest Capital Management LP bought a new position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,687 shares of the financial services provider's stock, valued at approximately $563,000.
Several other hedge funds also recently modified their holdings of the business. SBI Securities Co. Ltd. acquired a new position in Trupanion in the 4th quarter valued at approximately $25,000. Jones Financial Companies Lllp boosted its stake in Trupanion by 71.7% during the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock worth $27,000 after acquiring an additional 238 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Trupanion in the third quarter valued at approximately $54,000. Aster Capital Management DIFC Ltd boosted its position in Trupanion by 988.5% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider's stock worth $55,000 after acquiring an additional 1,028 shares during the last quarter. Finally, KBC Group NV bought a new position in shares of Trupanion in the 4th quarter valued at about $75,000.
Trupanion Stock Performance
Shares of NASDAQ TRUP traded down $0.12 during trading on Thursday, reaching $36.48. 236,293 shares of the company traded hands, compared to its average volume of 656,206. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90. The stock has a market capitalization of $1.55 billion, a PE ratio of -158.78, a P/E/G ratio of 6.02 and a beta of 1.66. The firm has a 50 day simple moving average of $35.32 and a 200-day simple moving average of $45.08.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). The firm had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Equities research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on TRUP. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Piper Sandler reduced their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $46.60.
Read Our Latest Stock Report on TRUP
Insider Transactions at Trupanion
In other news, CEO Margaret Tooth sold 2,294 shares of the company's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now owns 118,784 shares of the company's stock, valued at $3,728,629.76. This represents a 1.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the sale, the chief financial officer now owns 2,416 shares of the company's stock, valued at approximately $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,792 shares of company stock valued at $1,122,802. Corporate insiders own 5.50% of the company's stock.
About Trupanion
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.